Critical Roles for Lipomannan and Lipoarabinomannan in Cell Wall Integrity of Mycobacteria and Pathogenesis of Tuberculosis
Lipomannan (LM) and lipoarabinomannan (LAM) are mycobacterial glycolipids containing a long mannose polymer. While they are implicated in immune modulations, the significance of LM and LAM as structural components of the mycobacterial cell wall remains unknown. We have previously reported that a bra...
Saved in:
Published in | mBio Vol. 4; no. 1; p. e00472 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
American Society of Microbiology
01.03.2013
American Society for Microbiology |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Lipomannan (LM) and lipoarabinomannan (LAM) are mycobacterial glycolipids containing a long mannose polymer. While they are implicated in immune modulations, the significance of LM and LAM as structural components of the mycobacterial cell wall remains unknown. We have previously reported that a branch-forming mannosyltransferase plays a critical role in controlling the sizes of LM and LAM and that deletion or overexpression of this enzyme results in gross changes in LM/LAM structures. Here, we show that such changes in LM/LAM structures have a significant impact on the cell wall integrity of mycobacteria. In
Mycobacterium smegmatis
, structural defects in LM and LAM resulted in loss of acid-fast staining, increased sensitivity to β-lactam antibiotics, and faster killing by THP-1 macrophages. Furthermore, equivalent
Mycobacterium tuberculosis
mutants became more sensitive to β-lactams, and one mutant showed attenuated virulence in mice. Our results revealed previously unknown structural roles for LM and LAM and further demonstrated that they are important for the pathogenesis of tuberculosis.
IMPORTANCE
Tuberculosis (TB) is a global burden, affecting millions of people worldwide.
Mycobacterium tuberculosis
is a causative agent of TB, and understanding the biology of
M. tuberculosis
is essential for tackling this devastating disease. The cell wall of
M. tuberculosis
is highly impermeable and plays a protective role in establishing infection. Among the cell wall components, LM and LAM are major glycolipids found in all
Mycobacterium
species, show various immunomodulatory activities, and have been thought to play roles in TB pathogenesis. However, the roles of LM and LAM as integral parts of the cell wall structure have not been elucidated. Here we show that LM and LAM play critical roles in the integrity of mycobacterial cell wall and the pathogenesis of TB. These findings will now allow us to seek the possibility that the LM/LAM biosynthetic pathway is a chemotherapeutic target.
Tuberculosis (TB) is a global burden, affecting millions of people worldwide.
Mycobacterium tuberculosis
is a causative agent of TB, and understanding the biology of
M. tuberculosis
is essential for tackling this devastating disease. The cell wall of
M. tuberculosis
is highly impermeable and plays a protective role in establishing infection. Among the cell wall components, LM and LAM are major glycolipids found in all
Mycobacterium
species, show various immunomodulatory activities, and have been thought to play roles in TB pathogenesis. However, the roles of LM and LAM as integral parts of the cell wall structure have not been elucidated. Here we show that LM and LAM play critical roles in the integrity of mycobacterial cell wall and the pathogenesis of TB. These findings will now allow us to seek the possibility that the LM/LAM biosynthetic pathway is a chemotherapeutic target. |
---|---|
AbstractList | ABSTRACT Lipomannan (LM) and lipoarabinomannan (LAM) are mycobacterial glycolipids containing a long mannose polymer. While they are implicated in immune modulations, the significance of LM and LAM as structural components of the mycobacterial cell wall remains unknown. We have previously reported that a branch-forming mannosyltransferase plays a critical role in controlling the sizes of LM and LAM and that deletion or overexpression of this enzyme results in gross changes in LM/LAM structures. Here, we show that such changes in LM/LAM structures have a significant impact on the cell wall integrity of mycobacteria. In Mycobacterium smegmatis, structural defects in LM and LAM resulted in loss of acid-fast staining, increased sensitivity to β-lactam antibiotics, and faster killing by THP-1 macrophages. Furthermore, equivalent Mycobacterium tuberculosis mutants became more sensitive to β-lactams, and one mutant showed attenuated virulence in mice. Our results revealed previously unknown structural roles for LM and LAM and further demonstrated that they are important for the pathogenesis of tuberculosis. IMPORTANCE Tuberculosis (TB) is a global burden, affecting millions of people worldwide. Mycobacterium tuberculosis is a causative agent of TB, and understanding the biology of M. tuberculosis is essential for tackling this devastating disease. The cell wall of M. tuberculosis is highly impermeable and plays a protective role in establishing infection. Among the cell wall components, LM and LAM are major glycolipids found in all Mycobacterium species, show various immunomodulatory activities, and have been thought to play roles in TB pathogenesis. However, the roles of LM and LAM as integral parts of the cell wall structure have not been elucidated. Here we show that LM and LAM play critical roles in the integrity of mycobacterial cell wall and the pathogenesis of TB. These findings will now allow us to seek the possibility that the LM/LAM biosynthetic pathway is a chemotherapeutic target. Lipomannan (LM) and lipoarabinomannan (LAM) are mycobacterial glycolipids containing a long mannose polymer. While they are implicated in immune modulations, the significance of LM and LAM as structural components of the mycobacterial cell wall remains unknown. We have previously reported that a branch-forming mannosyltransferase plays a critical role in controlling the sizes of LM and LAM and that deletion or overexpression of this enzyme results in gross changes in LM/LAM structures. Here, we show that such changes in LM/LAM structures have a significant impact on the cell wall integrity of mycobacteria. In Mycobacterium smegmatis, structural defects in LM and LAM resulted in loss of acid-fast staining, increased sensitivity to β-lactam antibiotics, and faster killing by THP-1 macrophages. Furthermore, equivalent Mycobacterium tuberculosis mutants became more sensitive to β-lactams, and one mutant showed attenuated virulence in mice. Our results revealed previously unknown structural roles for LM and LAM and further demonstrated that they are important for the pathogenesis of tuberculosis. IMPORTANCE Tuberculosis (TB) is a global burden, affecting millions of people worldwide. Mycobacterium tuberculosis is a causative agent of TB, and understanding the biology of M. tuberculosis is essential for tackling this devastating disease. The cell wall of M. tuberculosis is highly impermeable and plays a protective role in establishing infection. Among the cell wall components, LM and LAM are major glycolipids found in all Mycobacterium species, show various immunomodulatory activities, and have been thought to play roles in TB pathogenesis. However, the roles of LM and LAM as integral parts of the cell wall structure have not been elucidated. Here we show that LM and LAM play critical roles in the integrity of mycobacterial cell wall and the pathogenesis of TB. These findings will now allow us to seek the possibility that the LM/LAM biosynthetic pathway is a chemotherapeutic target.Lipomannan (LM) and lipoarabinomannan (LAM) are mycobacterial glycolipids containing a long mannose polymer. While they are implicated in immune modulations, the significance of LM and LAM as structural components of the mycobacterial cell wall remains unknown. We have previously reported that a branch-forming mannosyltransferase plays a critical role in controlling the sizes of LM and LAM and that deletion or overexpression of this enzyme results in gross changes in LM/LAM structures. Here, we show that such changes in LM/LAM structures have a significant impact on the cell wall integrity of mycobacteria. In Mycobacterium smegmatis, structural defects in LM and LAM resulted in loss of acid-fast staining, increased sensitivity to β-lactam antibiotics, and faster killing by THP-1 macrophages. Furthermore, equivalent Mycobacterium tuberculosis mutants became more sensitive to β-lactams, and one mutant showed attenuated virulence in mice. Our results revealed previously unknown structural roles for LM and LAM and further demonstrated that they are important for the pathogenesis of tuberculosis. IMPORTANCE Tuberculosis (TB) is a global burden, affecting millions of people worldwide. Mycobacterium tuberculosis is a causative agent of TB, and understanding the biology of M. tuberculosis is essential for tackling this devastating disease. The cell wall of M. tuberculosis is highly impermeable and plays a protective role in establishing infection. Among the cell wall components, LM and LAM are major glycolipids found in all Mycobacterium species, show various immunomodulatory activities, and have been thought to play roles in TB pathogenesis. However, the roles of LM and LAM as integral parts of the cell wall structure have not been elucidated. Here we show that LM and LAM play critical roles in the integrity of mycobacterial cell wall and the pathogenesis of TB. These findings will now allow us to seek the possibility that the LM/LAM biosynthetic pathway is a chemotherapeutic target. Lipomannan (LM) and lipoarabinomannan (LAM) are mycobacterial glycolipids containing a long mannose polymer. While they are implicated in immune modulations, the significance of LM and LAM as structural components of the mycobacterial cell wall remains unknown. We have previously reported that a branch-forming mannosyltransferase plays a critical role in controlling the sizes of LM and LAM and that deletion or overexpression of this enzyme results in gross changes in LM/LAM structures. Here, we show that such changes in LM/LAM structures have a significant impact on the cell wall integrity of mycobacteria. In Mycobacterium smegmatis , structural defects in LM and LAM resulted in loss of acid-fast staining, increased sensitivity to β-lactam antibiotics, and faster killing by THP-1 macrophages. Furthermore, equivalent Mycobacterium tuberculosis mutants became more sensitive to β-lactams, and one mutant showed attenuated virulence in mice. Our results revealed previously unknown structural roles for LM and LAM and further demonstrated that they are important for the pathogenesis of tuberculosis. IMPORTANCE Tuberculosis (TB) is a global burden, affecting millions of people worldwide. Mycobacterium tuberculosis is a causative agent of TB, and understanding the biology of M. tuberculosis is essential for tackling this devastating disease. The cell wall of M. tuberculosis is highly impermeable and plays a protective role in establishing infection. Among the cell wall components, LM and LAM are major glycolipids found in all Mycobacterium species, show various immunomodulatory activities, and have been thought to play roles in TB pathogenesis. However, the roles of LM and LAM as integral parts of the cell wall structure have not been elucidated. Here we show that LM and LAM play critical roles in the integrity of mycobacterial cell wall and the pathogenesis of TB. These findings will now allow us to seek the possibility that the LM/LAM biosynthetic pathway is a chemotherapeutic target. Lipomannan (LM) and lipoarabinomannan (LAM) are mycobacterial glycolipids containing a long mannose polymer. While they are implicated in immune modulations, the significance of LM and LAM as structural components of the mycobacterial cell wall remains unknown. We have previously reported that a branch-forming mannosyltransferase plays a critical role in controlling the sizes of LM and LAM and that deletion or overexpression of this enzyme results in gross changes in LM/LAM structures. Here, we show that such changes in LM/LAM structures have a significant impact on the cell wall integrity of mycobacteria. In Mycobacterium smegmatis , structural defects in LM and LAM resulted in loss of acid-fast staining, increased sensitivity to β-lactam antibiotics, and faster killing by THP-1 macrophages. Furthermore, equivalent Mycobacterium tuberculosis mutants became more sensitive to β-lactams, and one mutant showed attenuated virulence in mice. Our results revealed previously unknown structural roles for LM and LAM and further demonstrated that they are important for the pathogenesis of tuberculosis. Tuberculosis (TB) is a global burden, affecting millions of people worldwide. Mycobacterium tuberculosis is a causative agent of TB, and understanding the biology of M. tuberculosis is essential for tackling this devastating disease. The cell wall of M. tuberculosis is highly impermeable and plays a protective role in establishing infection. Among the cell wall components, LM and LAM are major glycolipids found in all Mycobacterium species, show various immunomodulatory activities, and have been thought to play roles in TB pathogenesis. However, the roles of LM and LAM as integral parts of the cell wall structure have not been elucidated. Here we show that LM and LAM play critical roles in the integrity of mycobacterial cell wall and the pathogenesis of TB. These findings will now allow us to seek the possibility that the LM/LAM biosynthetic pathway is a chemotherapeutic target. Lipomannan (LM) and lipoarabinomannan (LAM) are mycobacterial glycolipids containing a long mannose polymer. While they are implicated in immune modulations, the significance of LM and LAM as structural components of the mycobacterial cell wall remains unknown. We have previously reported that a branch-forming mannosyltransferase plays a critical role in controlling the sizes of LM and LAM and that deletion or overexpression of this enzyme results in gross changes in LM/LAM structures. Here, we show that such changes in LM/LAM structures have a significant impact on the cell wall integrity of mycobacteria. In Mycobacterium smegmatis , structural defects in LM and LAM resulted in loss of acid-fast staining, increased sensitivity to β-lactam antibiotics, and faster killing by THP-1 macrophages. Furthermore, equivalent Mycobacterium tuberculosis mutants became more sensitive to β-lactams, and one mutant showed attenuated virulence in mice. Our results revealed previously unknown structural roles for LM and LAM and further demonstrated that they are important for the pathogenesis of tuberculosis. IMPORTANCE Tuberculosis (TB) is a global burden, affecting millions of people worldwide. Mycobacterium tuberculosis is a causative agent of TB, and understanding the biology of M. tuberculosis is essential for tackling this devastating disease. The cell wall of M. tuberculosis is highly impermeable and plays a protective role in establishing infection. Among the cell wall components, LM and LAM are major glycolipids found in all Mycobacterium species, show various immunomodulatory activities, and have been thought to play roles in TB pathogenesis. However, the roles of LM and LAM as integral parts of the cell wall structure have not been elucidated. Here we show that LM and LAM play critical roles in the integrity of mycobacterial cell wall and the pathogenesis of TB. These findings will now allow us to seek the possibility that the LM/LAM biosynthetic pathway is a chemotherapeutic target. Tuberculosis (TB) is a global burden, affecting millions of people worldwide. Mycobacterium tuberculosis is a causative agent of TB, and understanding the biology of M. tuberculosis is essential for tackling this devastating disease. The cell wall of M. tuberculosis is highly impermeable and plays a protective role in establishing infection. Among the cell wall components, LM and LAM are major glycolipids found in all Mycobacterium species, show various immunomodulatory activities, and have been thought to play roles in TB pathogenesis. However, the roles of LM and LAM as integral parts of the cell wall structure have not been elucidated. Here we show that LM and LAM play critical roles in the integrity of mycobacterial cell wall and the pathogenesis of TB. These findings will now allow us to seek the possibility that the LM/LAM biosynthetic pathway is a chemotherapeutic target. |
Author | Morita, Yasu S. Murakami, Yoshiko Kinoshita, Taroh Fukuda, Takeshi Ato, Manabu Maeda, Yusuke Matsumura, Takayuki Yoshimori, Tamotsu Kobayashi, Kazuo Hamasaki, Maho Nishiuchi, Yukiko Matsumoto, Sohkichi |
Author_xml | – sequence: 1 givenname: Takeshi surname: Fukuda fullname: Fukuda, Takeshi organization: Research Institute for Microbial Diseases, WPI-Immunology Frontier Research Center, Osaka University, Osaka, Japan – sequence: 2 givenname: Takayuki surname: Matsumura fullname: Matsumura, Takayuki organization: Department of Immunology, National Institute of Infectious Diseases, Tokyo, Japan – sequence: 3 givenname: Manabu surname: Ato fullname: Ato, Manabu organization: Department of Immunology, National Institute of Infectious Diseases, Tokyo, Japan – sequence: 4 givenname: Maho surname: Hamasaki fullname: Hamasaki, Maho organization: Department of Genetics, Graduate School of Medicine, Osaka University, Osaka, Japan – sequence: 5 givenname: Yukiko surname: Nishiuchi fullname: Nishiuchi, Yukiko organization: Department of Bacteriology, Osaka City University Graduate School of Medicine, Osaka, Japan – sequence: 6 givenname: Yoshiko surname: Murakami fullname: Murakami, Yoshiko organization: Research Institute for Microbial Diseases, WPI-Immunology Frontier Research Center, Osaka University, Osaka, Japan – sequence: 7 givenname: Yusuke surname: Maeda fullname: Maeda, Yusuke organization: Research Institute for Microbial Diseases, WPI-Immunology Frontier Research Center, Osaka University, Osaka, Japan – sequence: 8 givenname: Tamotsu surname: Yoshimori fullname: Yoshimori, Tamotsu organization: Department of Genetics, Graduate School of Medicine, Osaka University, Osaka, Japan – sequence: 9 givenname: Sohkichi surname: Matsumoto fullname: Matsumoto, Sohkichi organization: Department of Bacteriology, Osaka City University Graduate School of Medicine, Osaka, Japan – sequence: 10 givenname: Kazuo surname: Kobayashi fullname: Kobayashi, Kazuo organization: Department of Immunology, National Institute of Infectious Diseases, Tokyo, Japan – sequence: 11 givenname: Taroh surname: Kinoshita fullname: Kinoshita, Taroh organization: Research Institute for Microbial Diseases, WPI-Immunology Frontier Research Center, Osaka University, Osaka, Japan – sequence: 12 givenname: Yasu S. surname: Morita fullname: Morita, Yasu S. organization: Research Institute for Microbial Diseases, WPI-Immunology Frontier Research Center, Osaka University, Osaka, Japan |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/23422411$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkt9rFDEQxxep2Fr76Kvsoy9bk0ku2X0R9PDHwYkiFR_D5MdeU_aSM9kVDv95s3dtsYKYh2Rm8pkvk8k8rU5CDK6qnlNySSm0r7ZvfbwkhEtoKDyqzoAuSCMXlJ7MtqANUOhOq4ucb0hZjNGWkSfVKTAOwCk9q34tkx-9waH-GgeX6z6meu13cYshYKgx2IOLCbUPd1Ef6qUbhvo7lm0VRrcpIvs69vWnvYkazeiSx0PyFxyv48YFl32egatJu2SmIRb_WfW4xyG7i9vzvPr2_t3V8mOz_vxhtXyzbowAGBvotOZOgJEEuFx0zHZg0VItKAime9sa7nhPrSVMdgXpLXZAdNshLGxP2Xm1OuraiDdql_wW015F9OoQiGmjMJUmDE5JwaUgoA0xjrdti8XrLSOtlkJAz4rW66PWbtJbZ40LY8LhgejDm-Cv1Sb-VGwhmRBzMS9vBVL8Mbk8qq3PpnQTg4tTVlRywSSRHfs_Ch0VhHLeFfTFn2Xd13P30QVojoBJMefk-nuEEjXPkppnSR1mqQgXnv3FGz_i6OP8Kj_8I-s3HdLN4w |
CitedBy_id | crossref_primary_10_1038_s41467_023_41431_2 crossref_primary_10_1016_j_compbiomed_2025_109677 crossref_primary_10_3389_fimmu_2017_01659 crossref_primary_10_1021_acssensors_8b00393 crossref_primary_10_1016_j_tube_2018_09_007 crossref_primary_10_1128_mbio_00322_25 crossref_primary_10_1093_femsre_fuz006 crossref_primary_10_1186_s12917_019_2114_3 crossref_primary_10_3389_fimmu_2014_00455 crossref_primary_10_3390_ijms241914942 crossref_primary_10_1038_s41579_019_0273_7 crossref_primary_10_1093_femspd_fty026 crossref_primary_10_1016_j_tube_2022_102165 crossref_primary_10_4103_ijmr_IJMR_2055_16 crossref_primary_10_1371_journal_ppat_1004542 crossref_primary_10_1128_spectrum_03197_22 crossref_primary_10_3390_biom10030357 crossref_primary_10_1038_s41467_024_46565_5 crossref_primary_10_1016_j_cbpa_2021_05_009 crossref_primary_10_1021_jacs_3c09495 crossref_primary_10_1128_mBio_01823_17 crossref_primary_10_3390_ijms20246244 crossref_primary_10_2217_fmb_2017_0135 crossref_primary_10_1039_C5MB00476D crossref_primary_10_1002_iub_1331 crossref_primary_10_1016_j_jgg_2021_05_004 crossref_primary_10_1371_journal_pone_0113101 crossref_primary_10_1093_glycob_cwad096 crossref_primary_10_3390_ijms21196979 crossref_primary_10_1021_acsinfecdis_9b00008 crossref_primary_10_1111_sji_13261 crossref_primary_10_1042_BCJ20200194 crossref_primary_10_1099_mic_0_000605 crossref_primary_10_1128_mSphere_01039_20 crossref_primary_10_1186_s12864_015_1569_2 crossref_primary_10_3109_10409238_2014_925420 crossref_primary_10_1016_j_ebiom_2016_05_041 crossref_primary_10_1016_j_jlr_2024_100533 crossref_primary_10_1128_mbio_03396_22 crossref_primary_10_1016_j_tcsw_2022_100088 crossref_primary_10_3390_antibiotics10060693 crossref_primary_10_1016_j_apsb_2025_01_023 crossref_primary_10_1016_j_tube_2015_02_028 crossref_primary_10_1128_mSphere_00245_21 crossref_primary_10_1074_jbc_M117_804377 crossref_primary_10_1002_mas_21530 crossref_primary_10_1111_cmi_12175 crossref_primary_10_1021_acs_jmedchem_1c01870 crossref_primary_10_1093_glycob_cwab022 crossref_primary_10_1021_acs_joc_9b03064 crossref_primary_10_3390_cells11030361 crossref_primary_10_1128_JB_01346_13 crossref_primary_10_1126_scisignal_aaf1585 crossref_primary_10_3390_app10072278 crossref_primary_10_1021_acsabm_2c00026 crossref_primary_10_1002_jcla_25122 crossref_primary_10_1016_j_mib_2021_01_012 crossref_primary_10_1128_microbiolspec_TBTB2_0003_2015 crossref_primary_10_3389_fmicb_2023_1236599 crossref_primary_10_1093_femsle_fny025 crossref_primary_10_1016_j_bbalip_2016_11_002 crossref_primary_10_1128_JB_00419_21 crossref_primary_10_3389_fvets_2021_615029 crossref_primary_10_1016_j_ijbiomac_2024_129583 crossref_primary_10_1038_s41467_024_50051_3 crossref_primary_10_1016_j_jconrel_2023_07_013 crossref_primary_10_1016_j_jgg_2019_12_002 crossref_primary_10_3389_fcimb_2014_00187 crossref_primary_10_1016_j_micpath_2019_01_013 crossref_primary_10_1038_nature25177 crossref_primary_10_1007_s00430_016_0470_1 crossref_primary_10_1016_j_drudis_2016_09_025 crossref_primary_10_3390_separations9100271 crossref_primary_10_1080_14787210_2023_2224563 crossref_primary_10_1186_s12916_016_0603_9 crossref_primary_10_4049_jimmunol_1701673 crossref_primary_10_1021_acsinfecdis_4c00079 crossref_primary_10_3389_fcimb_2025_1498651 crossref_primary_10_1038_s41598_020_62287_2 crossref_primary_10_1021_acs_chemrev_1c00729 crossref_primary_10_3389_fimmu_2022_849321 crossref_primary_10_1016_j_nano_2014_02_012 crossref_primary_10_1016_j_tube_2019_02_008 crossref_primary_10_1016_j_cll_2020_08_010 crossref_primary_10_1007_s00284_017_1393_9 crossref_primary_10_1038_s42004_020_00356_3 |
Cites_doi | 10.1128/AAC.44.10.2845-2847.2000 10.1128/AAC.39.12.2620 10.1128/JB.186.20.6792-6799.2004 10.1128/AAC.00647-09 10.1073/pnas.85.18.6987 10.1074/jbc.M604214200 10.1038/nrmicro1861 10.1074/jbc.M511709200 10.1111/j.1365-2958.2004.04183.x 10.1016/S0021-9258(18)42686-5 10.1128/JB.00216-07 10.1074/jbc.M303446200 10.1074/jbc.M703389200 10.1128/JB.185.24.7103-7110.2003 10.1093/glycob/3.5.497 10.1016/S1472-9792(02)00089-6 10.1016/j.tube.2008.04.002 10.1111/j.1574-6976.2011.00276.x 10.1074/jbc.M603395200 10.1128/JB.01825-07 10.1016/j.bbagen.2011.03.017 10.1016/S0065-2164(09)69002-X 10.1073/pnas.0603049103 10.1046/j.1365-2958.2003.03425.x 10.1128/IAI.00974-07 10.1074/jbc.M109.077297 10.1016/S0021-9258(18)42685-3 10.1111/j.1462-5822.2007.01097.x 10.1002/path.1700580320 10.1074/jbc.R110.168328 10.1074/jbc.M806350200 10.1371/journal.pone.0015857 10.1111/j.1365-2818.2009.03299.x 10.1042/bj20031372 10.1073/pnas.0807761105 10.1016/j.tube.2010.02.003 10.1093/glycob/cwp042 10.1074/jbc.M109.049635 10.1111/j.1365-2958.2007.05884.x 10.1128/jb.8.2.121-126.1923 10.1016/S0021-9258(18)31404-2 10.1099/mic.0.27629-0 |
ContentType | Journal Article |
Copyright | Copyright © 2013 Fukuda et al. 2013 Fukuda et al. |
Copyright_xml | – notice: Copyright © 2013 Fukuda et al. 2013 Fukuda et al. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 7S9 L.6 5PM DOA |
DOI | 10.1128/mBio.00472-12 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic AGRICOLA AGRICOLA - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
DatabaseTitleList | MEDLINE - Academic AGRICOLA CrossRef MEDLINE |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
DocumentTitleAlternate | Role of Mycobacterial Mannan in Pathogenesis |
EISSN | 2150-7511 |
ExternalDocumentID | oai_doaj_org_article_7647602bc0ce4888a760fd308b7662f3 PMC3573661 23422411 10_1128_mBio_00472_12 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- 0R~ 53G 5VS AAFWJ AAGFI AAUOK AAYXX ADBBV ADRAZ AENEX AFPKN ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV BTFSW C1A CITATION DIK E3Z EBS EJD FRP GROUPED_DOAJ GX1 H13 HYE HZ~ KQ8 M48 O5R O5S O9- OK1 P2P PGMZT RHI RNS RPM RSF CGR CUY CVF ECM EIF M~E NPM RHF 7X8 7S9 L.6 5PM |
ID | FETCH-LOGICAL-c622t-29bb4e62c70247593d92dad1b61263bfd8c4e4f1dd0379247fda920b89a25df13 |
IEDL.DBID | M48 |
ISSN | 2161-2129 2150-7511 |
IngestDate | Wed Aug 27 01:31:27 EDT 2025 Thu Aug 21 14:14:21 EDT 2025 Fri Jul 11 08:07:51 EDT 2025 Thu Jul 10 23:36:17 EDT 2025 Wed Feb 19 02:31:33 EST 2025 Tue Jul 01 01:52:21 EDT 2025 Thu Apr 24 23:06:26 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
License | This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-ShareAlike 3.0 Unported license, which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original author and source are credited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c622t-29bb4e62c70247593d92dad1b61263bfd8c4e4f1dd0379247fda920b89a25df13 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Invited Editor William Bishai, Johns Hopkins University School of Medicine T.F. and T.M. contributed equally to this work. Present address: Yasu S. Morita, Department of Microbiology, University of Massachusetts, Amherst, Massachusetts, USA. Editor Keith Klugman, Emory University |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1128/mBio.00472-12 |
PMID | 23422411 |
PQID | 1291601449 |
PQPubID | 23479 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_7647602bc0ce4888a760fd308b7662f3 pubmedcentral_primary_oai_pubmedcentral_nih_gov_3573661 proquest_miscellaneous_1746370793 proquest_miscellaneous_1291601449 pubmed_primary_23422411 crossref_primary_10_1128_mBio_00472_12 crossref_citationtrail_10_1128_mBio_00472_12 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 20130301 |
PublicationDateYYYYMMDD | 2013-03-01 |
PublicationDate_xml | – month: 03 year: 2013 text: 20130301 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: 1752 N St., N.W., Washington, DC |
PublicationTitle | mBio |
PublicationTitleAlternate | mBio |
PublicationYear | 2013 |
Publisher | American Society of Microbiology American Society for Microbiology |
Publisher_xml | – name: American Society of Microbiology – name: American Society for Microbiology |
References | e_1_3_2_26_2 e_1_3_2_27_2 e_1_3_2_28_2 e_1_3_2_29_2 Schlesinger LS (e_1_3_2_25_2) 2008 e_1_3_2_41_2 e_1_3_2_40_2 e_1_3_2_20_2 e_1_3_2_43_2 e_1_3_2_21_2 e_1_3_2_42_2 e_1_3_2_22_2 e_1_3_2_45_2 e_1_3_2_23_2 e_1_3_2_44_2 e_1_3_2_46_2 e_1_3_2_9_2 e_1_3_2_15_2 e_1_3_2_38_2 e_1_3_2_8_2 e_1_3_2_16_2 e_1_3_2_37_2 e_1_3_2_7_2 e_1_3_2_17_2 e_1_3_2_6_2 e_1_3_2_18_2 e_1_3_2_39_2 e_1_3_2_19_2 e_1_3_2_30_2 e_1_3_2_32_2 e_1_3_2_10_2 e_1_3_2_31_2 e_1_3_2_5_2 e_1_3_2_11_2 e_1_3_2_34_2 e_1_3_2_4_2 e_1_3_2_12_2 e_1_3_2_33_2 e_1_3_2_3_2 e_1_3_2_13_2 e_1_3_2_36_2 e_1_3_2_14_2 e_1_3_2_35_2 World Health Organization (e_1_3_2_2_2) 2011 Gilleron M (e_1_3_2_24_2) 2008 |
References_xml | – ident: e_1_3_2_34_2 doi: 10.1128/AAC.44.10.2845-2847.2000 – ident: e_1_3_2_31_2 doi: 10.1128/AAC.39.12.2620 – ident: e_1_3_2_46_2 doi: 10.1128/JB.186.20.6792-6799.2004 – ident: e_1_3_2_41_2 doi: 10.1128/AAC.00647-09 – ident: e_1_3_2_39_2 doi: 10.1073/pnas.85.18.6987 – ident: e_1_3_2_13_2 doi: 10.1074/jbc.M604214200 – ident: e_1_3_2_36_2 doi: 10.1038/nrmicro1861 – ident: e_1_3_2_12_2 doi: 10.1074/jbc.M511709200 – ident: e_1_3_2_23_2 doi: 10.1111/j.1365-2958.2004.04183.x – ident: e_1_3_2_19_2 doi: 10.1016/S0021-9258(18)42686-5 – ident: e_1_3_2_45_2 doi: 10.1128/JB.00216-07 – ident: e_1_3_2_5_2 doi: 10.1074/jbc.M303446200 – ident: e_1_3_2_8_2 doi: 10.1074/jbc.M703389200 – ident: e_1_3_2_35_2 doi: 10.1128/JB.185.24.7103-7110.2003 – ident: e_1_3_2_18_2 doi: 10.1093/glycob/3.5.497 – volume-title: Global tuberculosis control: WHO report 2011 year: 2011 ident: e_1_3_2_2_2 – ident: e_1_3_2_3_2 doi: 10.1016/S1472-9792(02)00089-6 – ident: e_1_3_2_4_2 doi: 10.1016/j.tube.2008.04.002 – ident: e_1_3_2_11_2 doi: 10.1111/j.1574-6976.2011.00276.x – ident: e_1_3_2_21_2 doi: 10.1074/jbc.M603395200 – start-page: 75 volume-title: The mycobacterial cell envelope year: 2008 ident: e_1_3_2_24_2 – ident: e_1_3_2_27_2 doi: 10.1128/JB.01825-07 – ident: e_1_3_2_6_2 doi: 10.1016/j.bbagen.2011.03.017 – ident: e_1_3_2_10_2 doi: 10.1016/S0065-2164(09)69002-X – ident: e_1_3_2_14_2 doi: 10.1073/pnas.0603049103 – ident: e_1_3_2_22_2 doi: 10.1046/j.1365-2958.2003.03425.x – ident: e_1_3_2_30_2 doi: 10.1128/IAI.00974-07 – ident: e_1_3_2_15_2 doi: 10.1074/jbc.M109.077297 – start-page: 1 volume-title: Handbook of tuberculosis: immunology and cell biology year: 2008 ident: e_1_3_2_25_2 – ident: e_1_3_2_7_2 doi: 10.1016/S0021-9258(18)42685-3 – ident: e_1_3_2_38_2 doi: 10.1111/j.1462-5822.2007.01097.x – ident: e_1_3_2_32_2 doi: 10.1002/path.1700580320 – ident: e_1_3_2_9_2 doi: 10.1074/jbc.R110.168328 – ident: e_1_3_2_37_2 doi: 10.1074/jbc.M806350200 – ident: e_1_3_2_44_2 doi: 10.1371/journal.pone.0015857 – ident: e_1_3_2_40_2 doi: 10.1111/j.1365-2818.2009.03299.x – ident: e_1_3_2_43_2 doi: 10.1042/bj20031372 – ident: e_1_3_2_16_2 doi: 10.1073/pnas.0807761105 – ident: e_1_3_2_26_2 doi: 10.1016/j.tube.2010.02.003 – ident: e_1_3_2_28_2 doi: 10.1093/glycob/cwp042 – ident: e_1_3_2_29_2 doi: 10.1074/jbc.M109.049635 – ident: e_1_3_2_17_2 doi: 10.1111/j.1365-2958.2007.05884.x – ident: e_1_3_2_42_2 doi: 10.1128/jb.8.2.121-126.1923 – ident: e_1_3_2_20_2 doi: 10.1016/S0021-9258(18)31404-2 – ident: e_1_3_2_33_2 doi: 10.1099/mic.0.27629-0 |
SSID | ssj0000331830 |
Score | 2.3649392 |
Snippet | Lipomannan (LM) and lipoarabinomannan (LAM) are mycobacterial glycolipids containing a long mannose polymer. While they are implicated in immune modulations,... ABSTRACT Lipomannan (LM) and lipoarabinomannan (LAM) are mycobacterial glycolipids containing a long mannose polymer. While they are implicated in immune... |
SourceID | doaj pubmedcentral proquest pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | e00472 |
SubjectTerms | Animals Anti-Bacterial Agents - pharmacology beta-lactam antibiotics beta-lactams beta-Lactams - pharmacology biochemical pathways Cell Wall - metabolism Cell Wall - physiology cell wall components cell walls drug therapy Female glycolipids immunomodulation Lipopolysaccharides - metabolism macrophages Macrophages - immunology Macrophages - microbiology mannose Mice Mice, Inbred C57BL Microbial Viability mutants Mycobacterium smegmatis Mycobacterium smegmatis - drug effects Mycobacterium smegmatis - metabolism Mycobacterium smegmatis - pathogenicity Mycobacterium smegmatis - physiology Mycobacterium tuberculosis Mycobacterium tuberculosis - drug effects Mycobacterium tuberculosis - metabolism Mycobacterium tuberculosis - pathogenicity Mycobacterium tuberculosis - physiology pathogenesis people polymers protective effect tuberculosis Tuberculosis - microbiology virulence |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEBYhUOiltOlr06aoEHqqG-thyT42ISEtSSklgdyMnq1hI4fN7iH0z3dGXi-7oY9Lj5LHtqQZab6xh28I2be1C7KKttCYHCZ1ZIVRzBQBXIUWjcEQA7MtvqjTS_n5qrpaK_WFOWEDPfCwcAdaSa1Kbl0JD4VwzUArelHWVivFY-b5BJ-3FkzlM1igrZYjqSavD64Pu_5D5kYsGN9wQpmr_3cA836e5JrjOXlMHi0RI_04jPQJ2QpphzwYakjePSU_x2IF9BtyM1EAofSsu-mvTUomUZN8bpqZgRh47O0SPQrTKcXP6PRTZowANE77SM_vHOzwzOBs8s1fASL23_FE7G5R4GJhw8wtpj20n5HLk-OLo9NiWVGhcIrzecEba2VQ3GlwzbpqhG-4N55ZwDlK2OhrJ4OMzPtSaIjMdPSm4aWtQWmVj0w8J9upT-Elob5y3NSRhTJIGT3gTF6XNvAm2qiZZxPyflzi1i3pxrHqxbTNYQevW9RImzXSMj4h71biNwPPxp8ED1FfKyGkx84dYDTt0mjafxnNhLwdtd3CdsJ_JCaFfnELLwC8jFFm8xcZLZXIzIIT8mKwkNVwuJAIimD6esN2Nsa7eSV1PzKtt6i0ALS0-z8m-Io85LluBybLvSbb89ki7AF6mts3eaP8ArKbGR0 priority: 102 providerName: Directory of Open Access Journals |
Title | Critical Roles for Lipomannan and Lipoarabinomannan in Cell Wall Integrity of Mycobacteria and Pathogenesis of Tuberculosis |
URI | https://www.ncbi.nlm.nih.gov/pubmed/23422411 https://www.proquest.com/docview/1291601449 https://www.proquest.com/docview/1746370793 https://pubmed.ncbi.nlm.nih.gov/PMC3573661 https://doaj.org/article/7647602bc0ce4888a760fd308b7662f3 |
Volume | 4 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3di9NAEF_kRPBF_DZ-HCuIT-bMfiSbPIh44nkI-mShb2E3u3sG2s1d2qLFf96ZTVLtcedLYNNJG3ZmMr8J09-PkFembJzMvUkVDodJ5VmqC6ZTB6VCiUpji4HTFt-K05n8Ms_nfymFxg1cXdnaoZ7UrF8c_brYvoeEfzf8AaZ8uzxuu6NIe5ii3vBNKEoKxQy-jkg_PpQFBm82sWxevgo5gYXEcsb2ClTk8b8KfF6eofynKJ3cJXdGNEk_DO6_R264cJ_cGvQltw_I70nIgOIQ4YoCQKWL9rxb6hB0oDrYuNS9hv54OtsGim_z6U8Nh4FNApA67TxdbhvI_sjurOPFKGfcneHTsl2hwXpjXN9sFh2sH5LZyafvH0_TUW0hbQrO1ymvjJGu4I2Csq3yStiKW22ZAQxUCONt2UgnPbM2Ewq6NuWtrnhmSnBobj0Tj8hB6IJ7QqjNG65Lz1zmpPQWMCgvM-N45Y1XzLKEvJm2uG5GKnJUxFjUsSXhZY3OqaNzasYT8npnfj5wcFxneIz-2hkhdXY80fVn9ZiJtSqkKjJumgyiFPp_DStvRVYaVRTci4S8nLxdQ6rhjuvgus0KfgCwNHag1X9slCxEZB1MyOMhQna3M0VYQtRe7Ozd7_4nof0RKb9FrgQgqafXfuczcptHoQ6cjntODtb9xr0AuLQ2h_E1Axw_z9lhTIo_EwMW7Q |
linkProvider | Scholars Portal |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Critical+roles+for+lipomannan+and+lipoarabinomannan+in+cell+wall+integrity+of+mycobacteria+and+pathogenesis+of+tuberculosis&rft.jtitle=mBio&rft.au=Fukuda%2C+Takeshi&rft.au=Matsumura%2C+Takayuki&rft.au=Ato%2C+Manabu&rft.au=Hamasaki%2C+Maho&rft.date=2013-03-01&rft.eissn=2150-7511&rft.volume=4&rft.issue=1&rft.spage=e00472&rft_id=info:doi/10.1128%2FmBio.00472-12&rft_id=info%3Apmid%2F23422411&rft.externalDocID=23422411 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2161-2129&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2161-2129&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2161-2129&client=summon |